576
Views
5
CrossRef citations to date
0
Altmetric
Review Article

The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond – a report

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 717-732 | Received 24 Feb 2019, Accepted 05 May 2019, Published online: 20 Jun 2019

References

  • Albrecht, M. A., C. W. Evans, and C. L. Raston. 2006. “Green Chemistry and the Health Implications of Nanoparticles.” Green Chemistry 8(5): 417–432. doi:10.1039/b517131h.
  • Barnard, A. S. 2010. “One-to-One Comparison of Sunscreen Efficacy, Aesthetics and Potential Nanotoxicity.” Nature Nanotechnology 5(4): 271–274. doi:10.1038/nnano.2010.25.
  • Barua, S., and S. Mitragotri. 2014. “Challenges Associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.” Nano Today 9(2): 223–243. doi:10.1016/j.nantod.2014.04.008.
  • Bertoli, F., D. Garry, M. P. Monopoli, A. Salvati, and K. A. Dawson. 2016. “The Intracellular Destiny of the Protein Corona: A Study on Its Cellular Internalization and Evolution.” ACS Nano 10(11): 10471–10479. doi:10.1021/acsnano.6b06411.
  • Bertrand, N., P. Grenier, M. Mahmoudi, E. M. Lima, E. A. Appel, F. Dormont, J.-M. Lim, R. Karnik, R. Langer, and O. C. Farokhzad. 2017. “Mechanistic Understanding of In Vivo Protein Corona Formation on Polymeric Nanoparticles and Impact on Pharmacokinetics.” Nature Communications 8: 777. doi:10.1038/s41467-017-00600-w.
  • Bhattacharjee, S., L. H. J. De Haan, N. M. Evers, X. Jiang, A. T. M. Marcelis, H. Zuilhof, I. M. C. M. Rietjens, and G. M. Alink. 2010. “Role of Surface Charge and Oxidative Stress in Cytotoxicity of Organic Monolayer-Coated Silicon Nanoparticles towards Macrophage NR8383 Cells.” Particle and Fibre Toxicology 7(1): 25. doi:10.1186/1743-8977-7-25.
  • Bhattacharjee, S., D. Ershov, K. Fytianos, J. van der Gucht, G. M. Alink, I. M. C. M. Rietjens, A. T. M. Marcelis, and H. Zuilhof. 2012. “Cytotoxicity and Cellular Uptake of Tri-Block Copolymer Nanoparticles with Different Size and Surface Characteristics.” Particle and Fibre Toxicology 9(1): 11. doi:10.1186/1743-8977-9-11.
  • Bhattacharjee, S., I. M. C. M. Rietjens, M. P. Singh, T. M. Atkins, T. K. Purkait, Z. Xu, S. Regli., et al. 2013. “Cytotoxicity of Surface-Functionalized Silicon and Germanium Nanoparticles: The Dominant Role of Surface Charges.” Nanoscale 5(11): 4870–4883. doi:10.1039/c3nr34266b.
  • Bhattacharjee, S., E. J. van Opstal, G. M. Alink, A. T. M. Marcelis, H. Zuilhof, and I. M. C. M. Rietjens. 2013. “Surface Charge-Specific Interactions between Polymer Nanoparticles and ABC Transporters in Caco-2 Cells.” Journal of Nanoparticle Research 15: 1695.
  • Bhattacharjee, S., D. Ershov, M. A. Islam, A. M. Kämpfer, K. A. Maslowska, J. van der Gucht, G. M. Alink, A. T. M. Marcelis, H. Zuilhof, and I. M. C. M. Rietjens. 2014. “Role of Membrane Disturbance and Oxidative Stress in the Mode of Action Underlying the Toxicity of Differently Charged Polystyrene Nanoparticles.” RSC Advances 4(37): 19321–19330. doi:10.1039/C3RA46869K.
  • Bhattacharjee, S. 2016. “DLS and Zeta Potential – What They Are and What They Are Not?” Journal of Controlled Release 235: 337–351. doi:10.1016/j.jconrel.2016.06.017.
  • Bierkandt, F. S., L. Leibrock, S. Wagener, P. Laux, and A. Luch. 2018. “The Impact of Nanomaterial Characteristics on Inhalation Toxicity.” Toxicology Research 7: 321–346. doi:10.1039/C7TX00242D.
  • Borm, P. J. A., D. Robbins, S. Haubold, T. Kuhlbusch, H. Fissan, K. Donaldson, R. Schins, et al. 2006. “The Potential Risks of Nanomaterials: A Review Carried Out for ECETOC.” Particle and Fibre Toxicology 3(1): 11. doi:10.1186/1743-8977-3-11.
  • Boverhof, D. R., C. M. Bramante, J. H. Butala, S. F. Clancy, M. Lafranconi, J. West, and S. C. Gordon. 2015. “Comparative Assessment of Nanomaterial Definitions and Safety Evaluation Considerations.” Regulatory Toxicology and Pharmacology 73(1): 137–150. doi:10.1016/j.yrtph.2015.06.001.
  • Braakhuis, H. M., M. V. D. Z. Park, I. Gosens, W. H. De Jong, and F. R. Cassee. 2014. “Physicochemical Characteristics of Nanomaterials That Affect Pulmonary Inflammation.” Particle and Fibre Toxicology 11(1): 18. doi:10.1186/1743-8977-11-18.
  • Cedervall, T., I. Lynch, S. Lindman, T. Berggard, E. Thulin, H. Nilsson, K. A. Dawson, and S. Linse. 2007. “Understanding the Nanoparticle–Protein Corona Using Methods to Quantify Exchange Rates and Affinities of Proteins for Nanoparticles.” Proceedings of the National Academy of Sciences USA 104(7): 2050–2055. doi:10.1073/pnas.0608582104.
  • Chang, S., and S. H. Lamm. 2003. “Human Health Effects of Sodium Azide Exposure: A Literature Review and Analysis.” International Journal of Toxicology 22(3): 175–186. doi:10.1080/10915810305109.
  • Clift, M. J. D., B. Rothen-Rutishauser, D. M. Brown, R. Duffin, K. Donaldson, L. Proudfoot, K. Guy, and V. Stone. 2008. “The Impact of Different Nanoparticle Surface Chemistry and Size on Uptake and Toxicity in a Murine Macrophage Cell Line.” Toxicology and Applied Pharmacology 232(3): 418–427. doi:10.1016/j.taap.2008.06.009.
  • Delangle, P., and E. Mintz. 2012. “Chelation Therapy in Wilson's Disease: From d-Penicillamine to the Design of Selective Bioinspired Intracellular Cu(i) Chelators.” Dalton Transactions 41(21): 6359–6370. doi:10.1039/c2dt12188c.
  • Donaldson, K., R. Aitken, L. Tran, V. Stone, R. Duffin, G. Forrest, and A. Alexander. 2006. “Carbon Nanotubes: A Review of Their Properties in Relation to Pulmonary Toxicology and Workplace Safety.” Toxicological Sciences 92(1): 5–22. doi:10.1093/toxsci/kfj130.
  • Donaldson, K., F. A. Murphy, R. Duffin, and C. A. Poland. 2010. “Asbestos, Carbon Nanotubes and the Pleural Mesothelium: A Review of the Hypothesis regarding the Role of Long Fibre Retention in the Parietal Pleura, Inflammation and Mesothelioma.” Particle and Fibre Toxicology 7(1): 5. doi:10.1186/1743-8977-7-5.
  • EU Directives on Good Laboratory Practice 2004/9/EU and 2004/10/EU. Accessed April 15 2019. http://ec.europa.eu/growth/sectors/chemicals/good-laboratory-practice_en.
  • Fox, E. K., F. El Haddassi, J. Hierrezuelo, T. Ninjbadgar, J. K. Stolarczyk, J. Merlin, and D. F. Brougham. 2018. “Size-Controlled Nanoparticle Clusters of Narrow Size-Polydispersity Formed Using Multiple Particle Types through Competitive Stabilizer Desorption to a Liquid-Liquid Interface.” Small 14(44): 1802278. doi:10.1002/smll.201802278.
  • Giri, K., K. Shameer, M. T. Zimmermann, S. Saha, P. K. Chakraborty, A. Sharma, R. R. Arvizo, et al. 2014. “Understanding Protein-Nanoparticle Interaction: A New Gateway to Disease Therapeutics.” Bioconjugate Chemistry 25(6): 1078–1090. doi:10.1021/bc500084f.
  • Groso, A., A. Petri-Fink, A. Magrez, M. Riediker, and T. Meyer. 2010. “Management of Nanomaterials Safety in Research Environment.” Particle and Fibre Toxicology 7(1): 40. doi:10.1186/1743-8977-7-40.
  • Halappanavar, S., U. Vogel, H. Wallin, and C. L. Yauk. 2018. “Promise and Peril in Nanomedicine: The Challenges and Needs for Integrated Systems Biology Approaches to Define Health Risk.” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10(1): e1465. doi:10.1002/wnan.1465.
  • Ho, D., J. W. Leong, R. C. Crew, M. Norret, M. J. House, P. J. Mark, B. J. Waddell, K. S. Iyer, and J. A. Keelan. 2017. “Maternal-Placental-Fetal Biodistribution of Multimodal Polymeric Nanoparticles in a Pregnant Rat Model in Mid and Late Gestation.” Scientific Reports (Nature) 7: 2866. doi:10.1038/s41598-017-03128-7.
  • Jones, M.-C., S. A. Jones, Y. Riffo-Vasquez, D. Spina, E. Hoffman, A. Morgan, A. Patel, C. Page, B. Forbes, and L. A. Dailey. 2014. “Quantitative Assessment of Nanoparticle Surface Hydrophobicity and Its Influence on Pulmonary Biocompatibility.” Journal of Controlled Release 183: 94–104. doi:10.1016/j.jconrel.2014.03.022.
  • Karlsson, H. L., P. Cronholm, J. Gustafsson, and L. MöLler. 2008. “Copper Oxide Nanoparticles Are Highly Toxic: A Comparison between Metal Oxide Nanoparticles and Carbon Nanotubes.” Chemical Research in Toxicology 21(9): 1726–1732. doi:10.1021/tx800064j.
  • Kotchey, G. P., S. A. Hasan, A. A. Kapralov, S. H. Ha, K. Kim, A. A. Shvedova, V. E. Kagan, and A. Star. 2012. “A Natural Vanishing Act: The Enzyme-Catalyzed Degradation of Carbon Nanomaterials.” Accounts of Chemical Research 45(10): 1770–1781. doi:10.1021/ar300106h.
  • Lee, B. K., Y. H. Yun, and K. Park. 2015. “Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities.” Chemical Engineering Science 125: 158–164. doi:10.1016/j.ces.2014.06.042.
  • Leng, Y., L. Fu, L. Ye, B. Li, X. Xu, X. Xing, J. He, et al. 2016. “Protein-Directed Synthesis of Highly Monodispersed, Spherical Gold Nanoparticles and Their Applications in Multidimensional Sensing.” Scientific Reports 6: 28900.
  • Libretto, S. E. 1994. “A Review of the Toxicology of Salbutamol (Albuterol).” Archives of Toxicology 68(4): 213–216.
  • Lim, G. B. 2018. “Drug Delivery Using Inhaled Nanoparticles.” Nature Reviews Cardiology 15(3): 133. doi:10.1038/nrcardio.2018.11.
  • Lin, W. 2015. “Introduction: Nanoparticles in Medicine.” Chemical Reviews 115(19): 10407–10409. doi:10.1021/acs.chemrev.5b00534.
  • Liu, Z., S. Tabakman, K. Welsher, and H. Dai. 2009. “Carbon Nanotubes in Biology and Medicine: In Vitro and In Vivo Detection, Imaging and Drug Delivery.” Nano Research 2(2): 85–120. doi:10.1007/s12274-009-9009-8.
  • Long, T. C., J. Tajuba, P. Sama, N. Saleh, C. Swartz, J. Parker, S. Hester, G. V. Lowry, and B. Veronesi. 2007. “Nanosize Titanium Dioxide Stimulates Reactive Oxygen Species in Brain Microglia and Damages Neurons In Vitro.” Environmental Health Perspectives 115(11): 1631–1637. doi:10.1289/ehp.10216.
  • Loomis, D., K. Z. Guyton, Y. Grosse, F. El Ghissassi, V. Bouvard, L. Benbrahim-Tallaa, N. Guha, N. Vilahur, H. MAttock, and K. Straif. 2017. “Carcinogenicity of Benzene.” The Lancet Oncology 18(12): 1574–1575. doi:10.1016/S1470-2045(17)30832-X.
  • Lu, J., M. Liong, Z. Li, J. I. Zink, and F. Tamanoi. 2010. “Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals.” Small 6(16): 1794–1805. doi:10.1002/smll.201000538.
  • Lu, S., W. Zhang, R. Zhang, P. Liu, Q. Wang, Y. Shang, M. Wu, K. Donaldson, and Q. Wang. 2015. “Comparison of Cellular Toxicity Caused by Ambient Ultrafine Particles and Engineered Metal Oxide Nanoparticles.” Particle and Fibre Toxicology 12: 5. doi:10.1186/s12989-015-0082-8.
  • Luyts, K., D. Napierska, B. Nemery, and P. H. M. Hoet. 2013. “How Physico-Chemical Characteristics of Nanoparticles Cause Their Toxicity: complex and Unresolved Interrelations.” Environmental Science: Processes and Impacts 15: 23–38. doi:10.1039/C2EM30237C.
  • Mahon, E., D. R. Hristov, and K. A. Dawson. 2012. “Stabilising Fluorescent Silica Nanoparticles against Dissolution Effects for Biological Studies.” Chemical Communications 48(64): 7970–7972. doi:10.1039/c2cc34023b.
  • Maketon, W., C. Z. Zenner, and K. L. Ogden. 2008. “Removal Efficiency and Binding Mechanisms of Copper and Copper-EDTA Complexes Using Polyethyleneimine.” Environmental Science & Technology 42: 2124–2129. doi:10.1021/es702420h.
  • Massachusetts Institute of Technology (MIT) EHS (Environmental Health & Safety) Guidelines. Accessed April 15 2019. https://ehs.mit.edu/site/nanomaterials-toxicity.
  • Melville, L., S. M. I. Huq, and S. K. Khoda. 2016. “Understanding Bioenergy Production and Optimisation at the Nanoscale – A Review.” Journal of Experimental Nanoscience 11: 762–775. doi:10.1080/17458080.2016.1157905.
  • Miller, M. R., J. B. Raftis, J. P. Langrish, S. G. McLean, P. Samutrtai, S. P. Connell, S. Wilson, et al. 2017. “Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.” ACS Nano 11(5): 4542–4552. doi:10.1021/acsnano.6b08551.
  • Muoth, C., L. Aengenheister, M. Kucki, P. Wick, and T. Buerki-Thurnherr. 2016. “Nanoparticle Transport across the Placental Barrier: Pushing the Field Forward!” Nanomedicine (UK) 11(8): 941–957. doi:10.2217/nnm-2015-0012.
  • Murthy, S. K. 2007. “Nanoparticles in Modern Medicine: State of the Art and Future Challenges.” International Journal of Nanomedicine 2: 129–141.
  • Nakanishi, J., Y. Morimoto, I. Ogura, N. Kobayashi, M. Naya, M. Ema, S. Endoh, et al. 2015. “Risk Assessment of the Carbon Nanotube Group.” Risk Analysis: An Official Publication of the Society for Risk Analysis 35(10): 1940–1956. doi:10.1111/risa.12394.
  • Napierska, D., V. Rabolli, L. C. J. Thomassen, D. Dinsdale, C. Princen, L. Gonzalez, K. L. C. Poels, et al. 2012. “Oxidative Stress Induced by Pure and Iron-Doped Amorphous Silica Nanoparticles in Subtoxic Conditions.” Chemical Research in Toxicology 25(4): 828–837. doi:10.1021/tx200361v.
  • Navalon, S., and H. Garcia. 2016. “Nanoparticles for Catalysis.” Nanomaterials (Basel) 6: 123. doi:10.3390/nano6070123.
  • NHECD (EU FP7 funded initiative). Accessed April 15 2019. http://www.nhecd-fp7.eu/index.php?id=515.
  • Nystrom, A. M., and B. Fadeel. 2012. “Safety Assessment of Nanomaterials: Implications for Nanomedicine.” Journal of Controlled Release 161: 403–408. doi:10.1016/j.jconrel.2012.01.027.
  • Oberdorster, G., J. Ferin, R. Gelein, S. C. Soderholm, and J. Finkelstein. 1992. “Role of the Alveolar Macrophage in Lung Injury: Studies with Ultrafine Particles.” Environmental Health Perspectives 97: 193–199. doi:10.1289/ehp.97-1519541.
  • Oberdörster, G., and T. A. J. Kuhlbusch. 2018. “In Vivo Effects: Methodologies and Biokinetics of Inhaled Nanomaterials.” NanoImpact 10: 38–60. doi:10.1016/j.impact.2017.10.007.
  • Park, K. 2013. “Facing the Truth about Nanotechnology in Drug Delivery.” ACS Nano 7(9): 7442–7447. doi:10.1021/nn404501g.
  • Park, H. J., J.-H. Sohn, Y.-J. Kim, Y. H. Park, H. Han, K. H. Park, K. Lee, et al. 2015. “Acute Exposure to Silica Nanoparticles Aggravate Airway Inflammation: Different Effects According to Surface Characteristics.” Experimental and Molecular Medicine 47: e173. doi:10.1038/emm.2015.50.
  • Park, J., T. Kwon, J. Kim, H. Jin, H. Y. Kim, B. Kim, S. H. Joo, and K. Lee. 2018. “Hollow Nanoparticles as Emerging Electrocatalysts for Renewable Energy Conversion Reactions.” Chemical Society Reviews 47(22): 8173–8202. doi:10.1039/C8CS00336J.
  • Peters, R. J. B., G. van Bemmel, Z. Herrera-Rivera, H. P. F. G. Helsper, H. J. P. Marvin, S. Weigel, P. C. Tromp, A. G. Oomen, A. G. Rietveld, and H. Bouwmeester. 2014. “Characterization of Titanium Dioxide Nanoparticles in Food Products: Analytical Methods to Define Nanoparticles.” Journal of Agricultural and Food Chemistry 62(27): 6285–6293. doi:10.1021/jf5011885.
  • Poland, C. A., R. Duffin, I. Kinloch, A. Maynard, W. A. H. Wallace, A. Seaton, V. Stone, S. Brown, W. Macnee, and K. Donaldson. 2008. “Carbon Nanotubes Introduced into the Abdominal Cavity of Mice Show Asbestos-Like Pathogenicity in a Pilot Study.” Nature Nanotechnology 3(7): 423–428. doi:10.1038/nnano.2008.111.
  • Poulsen, S. S., P. Jackson, K. Kling, K. B. Knudsen, V. Skaug, Z. O. Kyjovska, B. L. Thomsen, et al. 2016. “Multi-Walled Carbon Nanotube Physicochemical Properties Predict Pulmonary Inflammation and Genotoxicity.” Nanotoxicology 10(9): 1263–1275. doi:10.1080/17435390.2016.1202351.
  • Ramsurn, H., and R. B. Gupta. 2013. “Nanotechnology in Solar and Biofuels.” ACS Sustainable Chemistry and Engineering 1: 779–797. doi:10.1021/sc400046y.
  • REACH (EC1907/2006) by the ECHA (European Chemicals Agency). Accessed 15 April 2019. http://ec.europa.eu/environment/chemicals/reach/reach_en.htm.
  • Roiter, Y., M. Ornatska, A. R. Rammohan, J. Balakrishnan, D. R. Heine, and S. Minko. 2008. “Interaction of Nanoparticles with Lipid Membrane.” Nano Letters 8(3): 941–944. doi:10.1021/nl080080l.
  • Ruizendaal, L., S. Bhattacharjee, K. Pournazari, M. Rosso-Vasic, L. H. J. De Haan, G. M. Alink, A. T. M. Marcelis, and H. Zuilhof. 2009. “Synthesis and Cytotoxicity of Silicon Nanoparticles with Covalently Attached Organic Monolayers.” Nanotoxicology 3(4): 339–347. doi:10.3109/17435390903288896.
  • Salata, O. V. 2004. “Applications of Nanoparticles in Biology and Medicine.” Journal of Nanobiotechnology 2(1): 3. doi:10.1186/1477-3155-2-3.
  • Samide, A., and B. Tutunaru. 2017. “Interactions between Vitamin C and Nanocolloidal Silver Particles Studied by Cyclic Voltammetry and UV-Vis Spectrophotometry.” Electroanalysis 29(11): 2498–2506. doi:10.1002/elan.201700281.
  • Semmler-Behnke, M., J. Lipka, A. Wenk, S. Hirn, M. Schaffler, F. R. Tian, G. Schmid, G. Oberdorster, and W. G. Kreyling. 2014. “Size Dependent Translocation and Fetal Accumulation of Gold Nanoparticles from Maternal Blood in the Rat.” Particle and Fibre Toxicology 11: 33. doi:10.1186/s12989-014-0033-9.
  • Saptarshi, S. R., A. Duschl, and A. L. Lopata. 2013. “Interaction of Nanoparticles with Proteins: Relation to Bio-Reactivity of the Nanoparticle.” Journal of Nanobiotechnology 11: 26. doi:10.1186/1477-3155-11-26.
  • Schmid, K., and M. Riediker. 2008. “Use of Nanoparticles in Swiss Industry: A Targeted Survey.” Environmental Science and Technology 42: 2253–2260. doi:10.1021/es071818o.
  • Schulte, P. A., V. Murashov, R. Zumwalde, E. D. Kuempel, and C. L. Geraci. 2010. “Occupational Exposure Limits for Nanomaterials: State of the Art.” Journal of Nanoparticle Research 12(6): 1971–1987. doi:10.1007/s11051-010-0008-1.
  • Sekhon, B. S. 2014. “Nanotechnology in Agri-Food Production: An Overview.” Nanotechnology, Science and Applications 7: 31–53. doi:10.2147/NSA.S39406.
  • Serrano, E., G. Rus, and J. Garcia-Martinez. 2009. “Nanotechnology for Sustainable Energy.” Renewable and Sustainable Energy Reviews 13(9): 2373–2384. doi:10.1016/j.rser.2009.06.003.
  • Sharifi, S., S. Behzadi, S. Laurent, M. L. Forrest, P. Stroeve, and M. Mahmoudi. 2012. “Toxicity of Nanomaterials.” Chemical Society Reviews 41(6): 2323–2343. doi:10.1039/c1cs15188f.
  • Shin, J. H., K. Jeon, J. K. Kim, Y. Kim, M. S. Jo, J. S. Lee, J. E. Baek, et al. 2017. “Subacute Inhalation Toxicity Study of Synthetic Amorphous Silica Nanoparticles in Sprague-Dawley Rats.” Inhalation Toxicology 29(12–14): 567–576. doi:10.1080/08958378.2018.1426661.
  • Singh, T., S. Shukla, P. Kumar, V. Wahla, V. K. Bajpai, and I. A. Rather. 2017. “Application of Nanotechnology in Food Science: Perception and Overview.” Frontiers in Microbiology 8(1501): 1–7. doi: 10.3389/fmicb.2017.01501
  • Stolarczyk, J. K., A. Deak, and D. F. Brougham. 2016. “Nanoparticle Clusters: Assembly and Control over Internal Order, Current Capabilities, and Future Potential.” Advanced Materials 28(27): 5400–5424. doi:10.1002/adma.201505350.
  • Stone, V., and K. Donaldson. 2007. “Toxicology of Nanoparticles: A Historical Perspective.” Nanotoxicology 1: 2–25. doi:10.1080/17435390701314761.
  • Stone, V., H. Johnston, and R. P. Schins. 2009. “Development of In Vitro Systems for Nanotoxicology: Methodological Considerations.” Critical Reviews in Toxicology 39(7): 613–626. doi:10.1080/10408440903120975.
  • Stone, V., M. R. Miller, M. J. D. Clift, A. Elder, N. L. Mills, P. Møller, R. P. F. Schins, et al. 2017. “Nanomaterials versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge.” Environmental Health Perspectives 125(10): 106002–106002. doi:10.1289/EHP424.
  • Sukhanova, A., S. Bozrova, P. Sokolov, M. Berestovoy, A. Karaulov, and I. Nabiev. 2018. “Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties.” Nanoscale Research Letters 13: 44–44. doi:10.1186/s11671-018-2457-x.
  • Taddei, E. B., V. A. R. Henriques, C. R. M. Silva, and C. A. A. Cairo. 2004. “Production of New Titanium Alloy for Orthopedic Implants.” Materials Science and Engineering: C 24(5): 683–687. doi:10.1016/j.msec.2004.08.011.
  • Teeguarden, J. G., P. M. Hinderliter, G. Orr, B. D. Thrall, and J. G. Pounds. 2007. “Particokinetics In Vitro: Dosimetry Considerations for In Vitro Nanoparticle Toxicity Assessments.” Toxicological Sciences 95(2): 300–312. doi:10.1093/toxsci/kfl165.
  • UCD Biosafety Manual 2008. Accessed April 15 2019. https://www.ucd.ie/t4cms/UCD%20Biosafety%20Manual%20.pdf.
  • UCD Workplace Safety Manual. Accessed April 15 2019. http://www.ucd.ie/sirc/healthsafety/workplacesafety/.
  • UCD Chemical Agents and Nanomaterials Safety Manual. Accessed April 15 2019. http://www.ucd.ie/sirc/healthsafety/workplacesafety/chemicalandnanomaterialsafety/.
  • UCD Standard Nanomaterial Risk Assessment Template. Accessed April 15 2019. https://www.ucd.ie/chem/t4media/UCD%20Nanomaterials%20Risk%20Assessment%20Template.pdf.
  • Ullmann, N., S. Caggiano, and R. Cutrera. 2015. “Salbutamol and around.” Italian Journal of Pediatrics 41(Suppl 2): A74. doi:10.1186/1824-7288-41-S2-A74.
  • University of Edinburgh Health and Safety Dept. Guidelines. Accessed April 15 2019. https://www.ed.ac.uk/health-safety/guidance/hazardous-substances/nanotechnologies.
  • van der Ploeg, M. J. C., J. H. J. van den Berg, S. Bhattacharjee, L. H. J. De Haan, D. S. Ershov, R. G. Fokkink, H. Zuilhof, I. M. C. M. Rietjens, and N. W. van den Brink. 2014. “In Vitro Nanoparticle Toxicity to Rat Alveolar Cells and Coelomocytes from the Earthworm Lumbricus Rubellus.” Nanotoxicology 8(1): 28–37. doi:10.3109/17435390.2012.744857.
  • Vilanova, O., J. J. Mittag, P. M. Kelly, S. Milani, K. A. Dawson, J. O. Radler, and G. Franzese. 2016. “Understanding the Kinetics of Protein-Nanoparticle Corona Formation.” ACS Nano 10(12): 10842–10850. doi:10.1021/acsnano.6b04858.
  • Wang, J., Y. Liu, F. Jiao, F. Lao, W. Li, Y. Gu, Y. Li, et al. 2008. “Time-Dependent Translocation and Potential Impairment on Central Nervous System by Intranasally Instilled TiO2 Nanoparticles.” Toxicology 254(1–2): 82–90. doi:10.1016/j.tox.2008.09.014.
  • Weir, A., P. Westerhoff, L. Fabricius, K. Hristovski, and N. von Goetz. 2012. “Titanium Dioxide Nanoparticles in Food and Personal Care Products.” Environmental Science and Technology 46: 2242–2250. doi:10.1021/es204168d.
  • Weissig, V., T. K. Pettinger, and N. Murdock. 2014. “Nanopharmaceuticals (Part 1): Products on the Market.” International Journal of Nanomedicine 9: 4357–4373. doi:10.2147/IJN.S46900.
  • Wilhelm, S., A. J. Tavares, Q. Dai, S. Ohta, J. Audet, H. F. Dvorak, and W. C. W. Chan. 2016. “Analysis of Nanoparticle Delivery to Tumours.” Nature Reviews Materials 1: 16014. doi:10.1038/natrevmats.2016.14.
  • Xia, T., M. Kovochich, M. Liong, L. Madler, B. Gilbert, H. Shi, J. I. Yeh, J. I. Zink, and A. E. Nel. 2008. “Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties.” ACS Nano 2(10): 2121–2134. doi:10.1021/nn800511k.
  • Xia, Y., H. Yang, and C. T. Campbell. 2013. “Nanoparticles for Catalysis.” Accounts of Chemical Research 46(8): 1671–1672. doi:10.1021/ar400148q.
  • Xu, L., H.-W. Liang, Y. Yang, and S.-H. Yu. 2018. “Stability and Reactivity: Positive and Negative Aspects for Nanoparticle Processing.” Chemical Reviews 118(7): 3209–3250. doi:10.1021/acs.chemrev.7b00208.
  • Zhang, L., F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, and O. C. Farokhzad. 2008. “Nanoparticles in Medicine: Therapeutic Applications and Developments.” Clinical Pharmacology & Therapeutics 83: 761–769. doi:10.1038/sj.clpt.6100400.
  • Zhao, Y., B. L. Allen, and A. Star. 2011. “Enzymatic Degradation of Multiwalled Carbon Nanotubes.” The Journal of Physical Chemistry A 115(34): 9536–9544. doi:10.1021/jp112324d.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.